Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Satoru MARUYAMA"'
Autor:
Taku Murakami, Keita Minami, Toru Harabayashi, Satoru Maruyama, Norikata Takada, Akira Kashiwagi, Haruka Miyata, Yasuyuki Sato, Ryuji Matsumoto, Hiroshi Kikuchi, Takashige Abe, Yoichi M. Ito, Sachiyo Murai, Nobuo Shinohara, Hiroshi Harada, Takahiro Osawa
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract We designed this multi-center prospective study with the following objectives: (1) the cross-sectional validation of extracellular vesicles (EV) mRNA markers to detect urothelial bladder cancer (UBC) before transurethral resection of bladder
Externí odkaz:
https://doaj.org/article/4da4ee68f2ad4cb49f113da6eed0e617
Autor:
Miho Sato, Takahiro Osawa, Takashige Abe, Michitaka Honda, Madoka Higuchi, Shuhei Yamada, Jun Furumido, Hiroshi Kikuchi, Ryuji Matsumoto, Yasuyuki Sato, Yoshihiro Sasaki, Toru Harabayashi, Satoru Maruyama, Norikata Takada, Keita Minami, Hiroshi Tanaka, Ken Morita, Akira Kashiwagi, Sachiyo Murai, Yoichi M. Ito, Katsuhiko Ogasawara, Nobuo Shinohara
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The Body Image Scale (BIS) is a 10-item tool that measures the body images of cancer patients. This study aims to validate the Japanese version of the BIS for bladder cancer patients. A multicenter cross-sectional survey was used to identify
Externí odkaz:
https://doaj.org/article/f9149ec6c9b0437ea19e83d9d4ed5932
Autor:
Hiroshi Kikuchi, Takahiro Osawa, Takashige Abe, Ryuji Matsumoto, Satoru Maruyama, Sachiyo Murai, Nobuo Shinohara
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0276816 (2022)
BackgroundThe quality of transurethral resection of bladder tumor (TURBT) markedly varies among surgeons and may have a considerable impact on treatment outcomes. The importance of a surgical checklist for TURBT has been suggested in order to standar
Externí odkaz:
https://doaj.org/article/c4dd857f64274e0b819b3a001ed47071
Autor:
Takahiro Osawa, Nobuo Shinohara, Satoru Maruyama, Koji Oba, Takashige Abe,, Shintaro Maru, Norikata Takada, Ataru Sazawa, Katsuya Nonomura
Publikováno v:
Urology Journal, Vol 10, Iss 1, Pp 784-789 (2013)
PURPOSE: To evaluate postoperative renal function and risk factors for the loss of renal function in patients who had undergone radical cystectomy. MATERIALS AND METHODS:A retrospective single institutional study evaluated 70 patients, including 54 m
Externí odkaz:
https://doaj.org/article/2652cbb666924b88971571428b14fb50
Autor:
Yosuke OTAKE, Satoru MARUYAMA
Publikováno v:
The Journal of The Institute of Electrical Engineers of Japan. 143:33-36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b40ea5e30ed3c1a66e2f5652981a7d77
https://doi.org/10.1541/ieejjournal.143.33
https://doi.org/10.1541/ieejjournal.143.33
Autor:
Takahiro Osawa, Miho Sato, Takashige Abe, Shuhei Yamada, Jun Furumido, Hiroshi Kikuchi, Ryuji Matsumoto, Yasuyuki Sato, Yoshihiro Sasaki, Toru Harabayashi, Satoru Maruyama, Norikata Takada, Keita Minami, Ken Morita, Sachiyo Murai, Katsuhiko Ogasawara, Nobuo Shinohara
Publikováno v:
Journal of Urology. 209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ed8e48ba3770f821a08aa865e11bd18
https://doi.org/10.1097/ju.0000000000003247.17
https://doi.org/10.1097/ju.0000000000003247.17
Autor:
Hiroshi Kikuchi, Takashige Abe, Ryuji Matsumoto, Takahiro Osawa, Satoru Maruyama, Sachiyo Murai, Nobuo Shinohara
Publikováno v:
International journal of urology. 29(3):251-258
Objectives We examined the outcomes of eight weekly bacillus Calmette-Guerin induction therapy after second transurethral resection, and investigated risk factors for intravesical recurrence or disease progression in high-risk non-muscle-invasive bla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03f44e0108e69d391543f1c8dac59f1e
http://hdl.handle.net/2115/84497
http://hdl.handle.net/2115/84497
Autor:
Kazuto Imai, Takashi Karashima, Yu Hidaka, Fumimasa Fukuta, Hiroshi Kitamura, Katsuhiro Ito, Hiroaki Matsumoto, Toru Shimazui, Hiroyuki Nishiyama, Kojiro Tashiro, Takahiro Kojima, Takehiko Segawa, Shin Higashi, Shintaro Narita, Naotaka Nishiyama, Satoshi Morita, Takashi Kobayashi, Tomoya Okuno, Kimihiko Masui, Shoichiro Mukai, Osamu Ogawa, Shigetaka Suekane, Masakazu Tsutsumi, Yuko Yoshio, Satoru Maruyama, Tomohiro Fukui, Seiji Nagasawa, Jun Miki
Publikováno v:
Journal of Geriatric Oncology. 13:88-93
We used real-world and large-scale data to assess the clinical efficacy and safety of pembrolizumab in older patients with advanced urothelial carcinoma (UC).A total of 608 patients who received pembrolizumab for the treatment of chemoresistant UC we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa4af5f1e095d7fa7b64e899436f659f
https://doi.org/10.1016/j.jgo.2021.07.002
https://doi.org/10.1016/j.jgo.2021.07.002
Autor:
Masaharu Inoue, Mikio Sugimoto, Ryuji Matsumoto, Toshihiro Saito, Hirohito Naito, Shinichi Sakamoto, Hiroshi Sasaki, Masaki Nakamura, Akira Yokomizo, Takuma Kato, Satoru Maruyama, Yoshiyuki Kakehi, Isao Hara, Yoichiro Tohi, Shin Egawa, Junichi Inokuchi, Katsuyoshi Hashine, Norihiko Kawamura, Hiroshi Fukuhara, Koji Mitsuzuka
Publikováno v:
International Journal of Clinical Oncology. 27:194-201
This study aimed to evaluate the pathological findings and oncological outcomes of deferred radical prostatectomy in patients who initially elected for active surveillance in a Japanese cohort. We retrospectively analyzed data collected from a multi-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb6cb2bd7b194015085a14f0745b370
https://doi.org/10.1007/s10147-021-02041-4
https://doi.org/10.1007/s10147-021-02041-4
Autor:
Yoshiyuki Kakehi, Hiromasa Tsukino, Osamu Ogawa, Yoichiro Tohi, Satoru Maruyama, Ryuji Matsumoto, Yasuyuki Sakai, Fukuta Fumimasa, Hiroshi Sasaki, Akira Yokomizo, Shinichi Sakamoto, Takuma Kato, Hiromi Hirama, Hiroshi Fukuhara, Toshihiro Saito, Yukio Naya, Mikio Sugimoto, Isao Hara, Katsuyoshi Hashine, Koji Mitsuzuka
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:666-671
There is no useful predictive marker for reclassification on active surveillance. Thus, we aimed to investigate thresholds of [−2] proPSA (p2PSA)-related parameters to predict reclassification of the first-year protocol biopsy (1-year PBx) and eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6058e4b354c0816befb601f115548f8d
https://doi.org/10.1038/s41391-021-00422-4
https://doi.org/10.1038/s41391-021-00422-4